Non-alcoholic Fatty Liver Disease in Morbidly Obese Individuals Undergoing Bariatric Surgery: Prevalence and Effect of the Pre-Bariatric Very Low Calorie Diet (original) (raw)
Obesity in Canada: a whole-of-society approach for healthier Canada. Senate. Standing Committee on Social Affairs SaT; 2016.
Table 105-0501 - Health indicator profile, annual estimates, by age group and sex, Canada, provinces, territories, health regions (2013 boundaries) and peer groups, occasional. Statistics Canada; 2013.
Courcoulas AP, Christian NJ, Belle SH, et al. Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA. 2013;310(22):2416–25. CASPubMedPubMed Central Google Scholar
Mostaedi R, Lackey DE, Adams SH, et al. Prevalence of undiagnosed and inadequately treated type 2 diabetes mellitus, hypertension, and dyslipidemia in morbidly obese patients who present for bariatric surgery. Obes Surg. 2014;24(6):927–35. ArticlePubMed Google Scholar
Sjostrom L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014 Jun 11;311(22):2297–304. ArticlePubMed Google Scholar
Hewitt S, Humerfelt S, Sovik TT, et al. Long-term improvements in pulmonary function 5 years after bariatric surgery. Obes Surg. 2014;24(5):705–11. ArticlePubMed Google Scholar
Mummadi RR, Kasturi KS, Chennareddygari S, et al. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2008;6(12):1396–402. ArticlePubMed Google Scholar
Colquitt JL, Picot J, Loveman E, et al. Surgery for obesity. Cochrane Database Syst Rev. 2009;15(2):CD003641. Google Scholar
Charrez B, Qiao L, Hebbard L. Hepatocellular carcinoma and non-alcoholic steatohepatitis: the state of play. World J Gastroenterol. 2016;22(8):2494–502. ArticleCASPubMedPubMed Central Google Scholar
Clark JM, Diehl AM. Hepatic steatosis and type 2 diabetes mellitus. Curr Diab Rep. 2002;2(3):210–5. ArticlePubMed Google Scholar
Bedogni G, Miglioli L, Masutti F, et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 2005;42(1):44–52. ArticlePubMed Google Scholar
Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40(6):1387–95. ArticlePubMed Google Scholar
Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34(3):274–85. ArticleCASPubMed Google Scholar
Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol. 2006;45(4):600–6. ArticlePubMed Google Scholar
Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52. ArticlePubMed Google Scholar
Moschen AR, Molnar C, Wolf AM, et al. Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression. J Hepatol. 2009;51(4):765–77. ArticleCASPubMed Google Scholar
Fris RJ. Preoperative low energy diet diminishes liver size. Obes Surg. 2004;14(9):1165–70. ArticlePubMed Google Scholar
Doyle A, Adeyi O, Khalili K, et al. Treatment with Optifast reduces hepatic steatosis and increases candidacy rates for living donor liver transplantation. Liver Transpl. 2016;22(9):1295–300. ArticlePubMed Google Scholar
Gastrointestinal surgery for severe obesity. Consensus statement / NIH Consensus Development Conference National Institutes of Health Consensus Development Conference. 1991 Mar 25-27;9(1):1-20.
Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9. ArticleCASPubMed Google Scholar
Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94(9):2467–74. ArticleCASPubMed Google Scholar
Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–5. ArticleCASPubMed Google Scholar
Saleh F, Doumouras AG, Gmora S, et al. Outcomes of the Ontario Bariatric Network: a cohort study. CMAJ Open. 2016;4(3):E383–E9. ArticlePubMedPubMed Central Google Scholar
Canadian Institute for Health Information. Bariatric surgery in Canada. Bariatric Surgery in Canada. Ottawa, ON: CIHI; 2014.
Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006;40(Suppl 1):S5–10. PubMed Google Scholar
Busetto L, Tregnaghi A, De Marchi F, et al. Liver volume and visceral obesity in women with hepatic steatosis undergoing gastric banding. Obes Res. 2002;10(5):408–11. ArticlePubMed Google Scholar
Nguyen NT, Longoria M, Gelfand DV, et al. Staged laparoscopic Roux-en-Y: a novel two-stage bariatric operation as an alternative in the super-obese with massively enlarged liver. Obes Surg. 2005;15(7):1077–81. ArticlePubMed Google Scholar
Lewis MC, Phillips ML, Slavotinek JP, et al. Change in liver size and fat content after treatment with Optifast® very low calorie diet. Obes Surg. 2006;16(6):697–701. ArticlePubMed Google Scholar
Frith J, Day CP, Henderson E, et al. Non-alcoholic fatty liver disease in older people. Gerontology. 2009;55(6):607–13. ArticleCASPubMed Google Scholar
Kelley DE, McKolanis TM, Hegazi RA, et al. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab. 2003;285(4):E906–16. ArticleCASPubMed Google Scholar
Luyckx FH, Lefebvre PJ, Scheen AJ. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab. 2000;26(2):98–106. CASPubMed Google Scholar
Adams LA, Feldstein AE. Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis. J Dig Dis. 2011;12(1):10–6. ArticleCASPubMed Google Scholar
Bugianesi E, Marchesini G, Gentilcore E, et al. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: role of insulin resistance and hepatic steatosis. Hepatology. 2006;44(6):1648–55. ArticleCASPubMed Google Scholar
Saponaro C, Gaggini M, Gastaldelli A. Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms. Curr Diab Rep. 2015;15(6):607. ArticlePubMed Google Scholar
Liu KH, Chan YL, Chan JC, et al. Mesenteric fat thickness as an independent determinant of fatty liver. Int J Obes. 2006;30(5):787–93. ArticleCAS Google Scholar
Kral JG, Schaffner F, Pierson Jr RN, et al. Body fat topography as an independent predictor of fatty liver. Metabolism. 1993;42(5):548–51. ArticleCASPubMed Google Scholar
Stefan N, Machicao F, Staiger H, et al. Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia. 2005;48(11):2282–91. ArticleCASPubMed Google Scholar
Faith JJ, McNulty NP, Rey FE, et al. Predicting a human gut microbiota’s response to diet in gnotobiotic mice. Science. 2011;333(6038):101–4. ArticleCASPubMedPubMed Central Google Scholar
Payne AN, Chassard C, Lacroix C. Gut microbial adaptation to dietary consumption of fructose, artificial sweeteners and sugar alcohols: implications for host-microbe interactions contributing to obesity. Obes Rev. 2012;13(9):799–809. ArticleCASPubMed Google Scholar
Moore WE, Moore LH. Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol. 1995;61(9):3202–7. CASPubMedPubMed Central Google Scholar
Spencer MD, Hamp TJ, Reid RW, et al. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology. 2011;140(3):976–86. ArticleCASPubMed Google Scholar
Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2005;172(7):899–905. ArticlePubMed Google Scholar
Wahlroos S, Phillips ML, Lewis MC, et al. Rapid significant weight loss and regional lipid deposition: implications for insulin sensitivity. Obes Res Clin Pract. 2007;1(1):1–78. ArticlePubMed Google Scholar
Gasteyger C, Larsen TM, Vercruysse F, et al. Effect of a dietary-induced weight loss on liver enzymes in obese subjects. Am J Clin Nutr. 2008;87(5):1141–7. ArticleCASPubMed Google Scholar
Hoy MK, Heshka S, Allison DB, et al. Reduced risk of liver-function-test abnormalities and new gallstone formation with weight loss on 3350-kJ (800-kcal) formula diets. Am J Clin Nutr. 1994;60(2):249–54. ArticleCASPubMed Google Scholar
Thoma C, Day CP, Trenell MI. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepatol. 2012 Jan;56(1):255–66. ArticlePubMed Google Scholar
Andersen T, Gluud C, Franzmann MB, et al. Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatol. 1991;12(2):224–9. ArticleCASPubMed Google Scholar
Ghadir MR, Riahin AA, Havaspour A, et al. The relationship between lipid profile and severity of liver damage in cirrhotic patients. Hepat Mon. 2010;10(4):285–8. PubMedPubMed Central Google Scholar
Selimoglu MA, Aydogdu S, Yagci RV. Lipid parameters in childhood cirrhosis and chronic liver disease. Pediatr Int. 2002;44(4):400–3. ArticleCASPubMed Google Scholar